Renal Replacement Therapy

SAN DIEGO — Preemptive continuous renal replacement therapy after therapeutic plasma exchange reduced mortality and improved other outcomes in patients with acute liver failure and cerebral edema, according to data from The Liver Meeting.

A biotechnology company developing compatible organs for transplantation to humans, eGenesis, secured financial backing that could eventually lead to a human trial of its bioengineered pig kidney, according to a company press release.

Diality has received FDA 510(k) clearance for its Moda-flx Hemodialysis System for acute and/or chronic renal failure, according to a press release.

Patients with advanced chronic kidney disease may benefit from angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use, but the antihypertensive agents may not reduce mortality risk, a retrospective analysis shows.

In 2019, former President Donald Trump signed the Advancing American Kidney Health initiative.

Nephrology providers have limited knowledge and experience in offering conservative kidney management to patients who decide to forgo renal replacement therapy, recently published survey results show.

Older adults with low eGFR based on creatinine and cystatin C levels may be at higher risk for adverse events compared with those who have low eGFR based on creatinine level, data show.

Patients with chronic kidney disease who followed a healthy or overall plant-based diet had a lower risk for all-cause mortality than those who followed an unhealthy plant-based diet, according to recently published data.

AWAK Technologies has received a breakthrough device designation from the FDA for its progression prediction model directed at patients with chronic kidney disease, according to a press release.

Long-term use of the potassium binder patiromer may improve clinical outcomes among patients with chronic kidney disease and hyperkalemia, according to a study.